Dynavax Technologies Corp (NASDAQ:DVAX)

CAPS Rating: 3 out of 5

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

Recs

0
Player Avatar jonmetz2000 (< 20) Submitted: 10/19/2010 11:08:31 AM : Outperform Start Price: $1.96 DVAX Score: +73.30

hepislav is a hit and will be approved.

Featured Broker Partners


Advertisement